Oruka Therapeutics, Inc. (ORKA) SEC Filings — 2024

Filings

• Oruka Therapeutics Signs Material Definitive Agreement — 8-K · Dec 19, 2024
• Fairmount Funds Adjusts Oruka Therapeutics Stake — SC 13D/A · Nov 21, 2024
• Oruka Therapeutics Files 8-K on Shareholder Votes — 8-K · Nov 18, 2024
• Oruka Therapeutics Files S-1 for Public Offering — S-1 · Nov 14, 2024
• Oruka Therapeutics, Inc. SC 13G/A Filing — SC 13G/A · Nov 14, 2024
• Oruka Therapeutics, Inc. SC 13G/A Filing — SC 13G/A · Nov 14, 2024
• Oruka Therapeutics, Inc. SC 13G/A Filing — SC 13G/A · Nov 14, 2024
• Oruka Therapeutics, Inc. SC 13G/A Filing — SC 13G/A · Nov 14, 2024
• Oruka Therapeutics Files Q3 2024 10-Q Report — 10-Q · Nov 13, 2024
• Adage Capital Management Amends Oruka Therapeutics Filing — SC 13D/A · Oct 22, 2024
• Oruka Therapeutics Files Definitive Proxy Statement — DEF 14A · Oct 18, 2024
• Oruka Therapeutics, Inc. SC 13G Filing — SC 13G · Oct 7, 2024
• Oruka Therapeutics Appoints New CEO, David Epstein — 8-K · Oct 4, 2024
• Oruka Therapeutics Files 8-K with Key Agreements and Filings — 8-K · Sep 13, 2024
• Fairmount Funds Discloses Stake in Oruka Therapeutics — SC 13D · Sep 6, 2024
• Oruka Therapeutics Acquired by 03 Life Sciences — 8-K · Sep 5, 2024
• ARCA biopharma to be Acquired by 03 Life Sciences — 8-K · Aug 27, 2024
• ARCA biopharma Files 8-K on Shareholder Votes & Other Events — 8-K · Aug 23, 2024
• ARCA biopharma Files 8-K — 8-K · Aug 16, 2024
• ARCA biopharma Files 8-K for Material Agreement — 8-K · Aug 15, 2024
• ARCA biopharma Files 10-Q Amidst Merger Activity — 10-Q · Aug 1, 2024
• ARCA biopharma Enters Material Definitive Agreement — 8-K · Jul 9, 2024
• Arca Biopharma, Inc. SC 13G/A Filing — SC 13G/A · Jul 5, 2024
• Arca Biopharma, Inc. SC 13G Filing — SC 13G · Apr 29, 2024
• ARCA biopharma, Inc. Files 10-Q for Period Ending March 31, 2024 — 10-Q · Apr 25, 2024
• ARCA biopharma Appoints New Chief Medical Officer — 8-K · Apr 23, 2024
• Arca Biopharma, Inc. SC 13G Filing — SC 13G · Apr 15, 2024
• Arca Biopharma, Inc. SC 13G Filing — SC 13G · Apr 11, 2024
• Arca Biopharma, Inc. SC 13G Filing — SC 13G · Apr 9, 2024
• Arca Biopharma, Inc. SC 13G/A Filing — SC 13G/A · Apr 5, 2024
• Adage Capital Management Reports Stake in ARCA biopharma — SC 13D · Apr 5, 2024
• ARCA biopharma Appoints New Chief Medical Officer — 8-K · Apr 4, 2024
• ARCA biopharma Files 8-K: Agreements, Equity Sales, Control Changes — 8-K · Apr 3, 2024
• ARCA biopharma Enters Material Definitive Agreement — 8-K · Mar 22, 2024
• BML Investment Partners Amends ARCA Biopharma Stake — SC 13G/A · Feb 7, 2024
• ARCA biopharma Files 8-K on Officer/Director Changes, Compensation — 8-K · Feb 6, 2024
• ARCA biopharma, Inc. Files 2023 Annual Report on Form 10-K — 10-K · Feb 1, 2024
• ARCA biopharma Reports Director/Officer Changes, Shareholder Vote — 8-K · Jan 31, 2024